Abstract
Background: Remote blood pressure (BP) monitoring (RBPM) or BP telemonitoring is beneficial in hypertension management. People with hypertension involved in telemonitoring of BP often have better BP control than those in usual care. However, most reports on RBPM are from intervention studies.
Objective: This study aimed to assess participant characteristics and technology health behaviors associated with RBPM participation in a wider population with hypertension. This study will help us understand the predictors of RBPM participation and consider how to increase it.
Methods: This was a quantitative, cross-sectional survey study of people with hypertension in the United States. The inclusion criteria included people aged ≥18 years with a hypertension diagnosis or who self-reported they have hypertension, had a prescription of at least one hypertension medication, understood the English language, and were willing to participate. The survey included demographics, technology health behaviors, and RBPM participation questions. The survey was self-administered on the Qualtrics platform and followed the CHERRIES (Checklist for Reporting Results of Internet E-Surveys) checklist. The primary dependent variable was participation in RBPM.
Results: In total, 507 people with hypertension participated in the survey. The mean age for all respondents was 60 (SD 14.7) years. The respondents were mostly female (306/507, 60.4%), non-Hispanic (483/507, 95.3%), and White (429/507, 84.6%). A little over half of the respondents reported having had hypertension for 5 years or more (287/507, 56.6%). About one-third of participants were aware of RBPM (165/507, 32.5%), and 11.8% (60/507) were enrolled in RBPM. The mean age of those engaging in RBPM and non-RBPM was 46.2 (SD 14.7) and 62 (SD 13.7) years, respectively. The most common reasons for not participating in RBPM were because their health provider did not ask the participant to participate (247/447, 55.3%) and their lack of awareness of RBPM (190/447, 42.5%). Most respondents in the RBPM group measure their BP at home (55/60, 91.7%), and 61.7% (37/60) engage in daily BP measurement, compared with 62.6% (280/447) and 25.1% (112/447), respectively, among the non-RBPM group. A greater number of those in the RBPM group reported tracking their BP measurements with mobile health (mHealth; 37/60, 61.7%) than those in the non-RBPM group (70/447, 15.6%). The electronic health records or patient portal was the most common channel of RBPM communication between the respondents and their health care providers. The significant predictors of participation in RBPM were RBPM awareness (adjusted odds ratio [AOR] 34.65, 95% CI 11.35‐150.31; P<.001) and sharing health information electronically with a health provider (AOR 4.90, 95% CI 1.39‐21.64; P=.01) among all participants. However, the significant predictor of participation in RBPM among participants who were aware of RBPM was sharing health information electronically with a health provider (AOR 6.99, 95% CI 1.62‐47.44; P=.007).
Conclusions: Participation in RBPM is likely to increase with increased awareness, health providers’ recommendations, and tailoring RBPM services to patients’ preferred electronic communication channels.
doi:10.2196/56954
Keywords
Introduction
Background
Remote blood pressure (BP) monitoring (RBPM) or BP telemonitoring is an important hypertension management strategy that involves electronic transfer of self-measured BP from the patient’s home to their doctor or doctor’s office with subsequent feedback based on the transmitted BP measurements [
]. RBPM offers many benefits to both patients and health care providers [ - ]. The patients can save time and cost of health care by reducing clinic visits, being more engaged in their disease management, and gaining a better understanding of their hypertension and how to keep it under control. Health care providers can follow their patients more closely, make timely health decisions, and provide improved quality of care to their patients. Various studies have demonstrated greater improvement in BP control among patients engaged in RBPM compared with those in usual care [ , , - ]. However, to reap the benefits of RBPM, patients need to engage in the RBPM program [ - ]. Patients’ engagement in RBPM depends on various factors which may be technology-, health system-, or patient-related. The technology needs to be simple and user-friendly. The health system is responsible for making these technological services available with adequate resources and manpower [ , ].Patient-related factors that may influence RBPM engagement include patient demographics, technology health behaviors, poor electronic health literacy, lack of understanding of the risks associated with uncontrolled hypertension, lack of access to simple adequate technologies, privacy concerns, health data integrity, and security [
, , , - ]. Technology health behaviors refer to technology-related actions taken by patients to improve their health. Technology health behaviors, such as electronic health information sharing between patients and their health care providers, have helped improve communication and decision-making between both parties [ ]. The health information sharing could be done through the electronic health portals or mobile health (mHealth) devices, including tablet computers and mobile phones. Adults with one or more chronic disease conditions including hypertension, are more likely to use mHealth to access Web-based health support from their health care providers compared with those without any chronic diseases [ ]. Patients with chronic diseases are also more likely to track health goals electronically, make health decisions, and hold discussions with their health care providers based on electronically found health information [ ]. A study on people with hypertension who responded to the Health Information National Trends Survey (HINTS) found that patients who are already engaging with their health care providers electronically via email or the internet have higher odds of also communicating through SMS text messages with them compared with those who are not [ ]. These studies, however, are not specific to RBPM.Most studies on RBPM are intervention studies. There is a lack of data on the prevalence of RBPM participation among people with hypertension in everyday life situations. Patient-related factors that influence engagement in RBPM have been driven mostly by qualitative studies [
- ] and less by the quantitative assessment of patients’ characteristics to identify predictors of engagement [ ]. Quantitative assessment of technology health behaviors focused on RBPM participation are therefore warranted.Objectives
The objectives of this study were to (1) assess participation and nonparticipation in RBPM among adults with hypertension and (2) assess patients’ characteristics and technology health behaviors that predict participation in RBPM. We hypothesized that participation in RBPM is associated with patients’ characteristics and technology health behaviors.
Methods
Design
The study was a quantitative cross-sectional survey of patients with hypertension in the United States.
Ethical Considerations
The study was approved by the University of Michigan Institutional Review Board with the approval number HUM00205760. Informed consent and the ability to opt out of the study were provided to the participants before they could participate in the study. Anonymized data containing no identifiable personal information were collected from the participants. The participants were compensated with the amount they agreed on with Qualtrics before entering the study.
Participants
The participants were recruited and surveyed using a web-based Qualtrics panel. Qualtrics panel members are real people whose names, addresses, and date of birth have been validated. Qualtrics recruits them from all over the United States to participate in surveys. The inclusion criteria were patients aged ≥18 years who self-reported a hypertension diagnosis, had at least one prescription hypertension medication, understood the English language, and were willing to participate. Exclusion criteria included active cancer, diagnosis of cognitive impairment, or having been to the intensive care unit in the past 6 months. We used the exclusion criteria because people with active cancer, cognitive impairment, or who were recently in intensive care unit were more likely to be closely monitored by their health care providers and may not provide the general RBPM practice obtainable in the hypertension population.
Sample Size
With the 47.3% adult population with hypertension in the United States in 2021 [
], using 5% type 1 error (P=.05), the minimum sample size required to estimate participation in RBPM was 383 participants [ ]. A minimum sample size of 500 has been recommended for the detection of differences between sample estimates and the population in observational studies involving logistic regression [ ]. We therefore recruited 507 participants with hypertension using the quota sampling explained in the recruitment section.Recruitment
The participants were recruited using the Qualtrics panel. Based on our preliminary study of a secondary analysis of the 2018 HINTS 5 Cycle 2, age and education were associated with electronic health information seeking among respondents with hypertension. Therefore, we used a priori quota sampling based on age and educational levels. To ensure adequate representation within the age and education groups, the following proportions from the analysis of HINTS 5 Cycle 2 respondents with hypertension were used: less than 50 years (15%), 50‐74 years (64%), 75 years and above (21%), less than college education (32%), some college education (34%), college graduate, and above (34%). The study, extent of participation, and incentive for participation, were described to the participants meeting the inclusion criteria. The participants were screened for study inclusion eligibility, and consented before they completed the survey. The participants were compensated based on the amount they agreed upon before entering the survey.
Data Collection
The web-based survey had 3 parts including demographics and clinical characteristics questions, BP self-monitoring and telemonitoring behavior questions, and technology health behavior questions. The survey was self-administered and took about 15 minutes to complete. The survey was in the field from November to December 2021. More information on the survey using the CHERRIES (Checklist for Reporting Results of Internet E-Surveys) checklist [
] is presented in .Demographics and Clinical Characteristics
We collected respondents’ demographics and clinical characteristics including age, sex, ethnicity, race, educational level, marital status, income, clinic distance from residence, residential area, general health status, comorbidities, length of time since being diagnosed with hypertension, number of hypertension medications, number of other medications different from the hypertension medications, BP control status, and the last measured systolic and diastolic BP values.
BP Self-Monitoring and Telemonitoring Behaviors
We collected data on respondents’ routine BP monitoring and tracking behaviors, RBPM awareness, participation and telemonitoring strategies used. We provided a description of RBPM to respondents like this: “Remote blood pressure monitoring is a newer way to keep control of your blood pressure from home. In remote blood pressure monitoring, you measure your BP at home and send the readings or measurements to your health care provider through an electronic means. You may or may not receive feedback from your provider electronically. You still visit the office for problems or yearly check-ups.” The questions used in the data collection were formulated from activities that patients usually must do in home BP monitoring and RBPM programs [
- ]. We also asked those not participating in RBPM to state their reasons for not participating and their likelihood of participation if RBPM were offered to them (very likely, somewhat likely, neither likely nor unlikely, somewhat unlikely, very unlikely).Technology Health Behaviors
For this survey section, we adapted variables from HINTS [
] focusing on technology ownership and use within a 12-month recall period. We also asked for patient-provider communication or interaction preferences regarding BP management, whether through in-person clinic visits or electronic means including email, phone calls, SMS text messages, electronic health records, and video visits. Participants who responded “no” to ownership of a home BP monitoring device were asked to state their reasons for not having it.Survey Pilot Testing
The web-based survey was first piloted among 12 volunteers from staff and graduate students and revised for clarity. The second pilot was through the Qualtrics panel to confirm the content validity and reliability before the full launch.
Statistical Analysis
Descriptive statistics were used to describe the respondents’ demographics, BP telemonitoring behaviors, and health technology behaviors. Categorical variables were reported as frequencies (n [%]), while continuous variables were reported as means and SD. Bivariate analysis using chi-square tests compared patients’ characteristics between RBPM and non-RBPM groups.
The outcome variable was participation in remote BP monitoring (RBPM). Independent variables included demographics, general health status, clinic distance from residence, RBPM awareness, and technology health behaviors. The independent variables used were adopted from factors that have been reported in literature to influence use of digital services [
, , , ]Firth’s [
, ] logistic regression was used to assess the predictors of participation in RBPM. Firth’s logistic regression uses a penalized likelihood approach to account for any separation in the categorical variables due to the small sample size and reduces bias in the parameter estimates. Demographics and technology behaviors were included in the regression model. Age and education interaction variables were also included. Education variables were recoded into 3 categories: less than college, some college, and college graduate or more. Race variables were recoded into two categories: White and other races. Marital status variables were recoded into 3 categories: never married, married, and previously married. Various regression models were fitted using the stepwise forward regression method, and the model with the lowest Akaike information criterion [ ] was chosen for the prediction. All analyses were performed using the R Studio software, version 4.2.1 (JJ Allaire and Posit).Results
Description of Participants’ Demographics and Clinical Characteristics
A total of 507 people with hypertension meeting the study criteria were consented to the study and surveyed. The mean age for all participants was 60 (SD 14.7) years (
). The respondents were mostly female (306/507, 60.4%), non-Hispanic (483/507, 95.3%), and White (429/507, 84.6%). Most of the respondents (398/507, 78.5%) lived within 10 miles from their clinics in urban (130/507, 25.6%), and suburban (245/507, 48.3%) areas. More than half reported having had hypertension for 5 years or more (287/507, 56.6%) with the majority reporting their hypertension under control (422/507, 83.2%). Depression or anxiety was the most reported comorbidity (203/507, 40%).A total of 60 respondents out of the 507 reported participation in RBPM giving a prevalence of 11.8% (
). The RBPM participation group had a significantly lower mean age (46.2, SD 14.7 y) than the non-RBPM participation group (62, SD 13.7 y). The RBPM participation group also had more people in the married category (53.3% vs 39.1%). The majority (75.1%) of those participating in RBPM reported less than 5 years since diagnosis of hypertension compared with 39.1% in the non-RBPM group ( ).Variable and category | All participants (N=507) | RBPM | participation, n=60 (11.8%)No RBPM participation, n=447 (88.2%) | P value | |
Age in years, mean (SD) | 60.09 (14.7) | 46.17 (14.71) | 61.96 (13.67) | <.001 | |
Age groups in years, n (%) | <.001 | ||||
Less than 50 | 83 (16.4) | 32 (53.3) | 51 (11.4) | ||
50‐74 | 318 (62.7) | 25 (41.7) | 293 (65.5) | ||
75 and above | 106 (20.9) | 3 (5) | 103 (23) | ||
Sex, n (%) | .30 | ||||
Male | 201 (39.6) | 28 (46.7) | 173 (38.7) | ||
Female | 306 (60.4) | 32 (53.3) | 274 (61.3) | ||
Ethnicity, n (%) | .09 | ||||
Hispanic | 24 (4.7) | 6 (10) | 18 (4) | ||
Non-Hispanic | 483 (95.3) | 54 (90) | 429 (96) | ||
Race, n (%) | .03 | ||||
American Indian or Alaska Native | 4 (0.8) | 2 (3.3) | 2 (0.4) | ||
Asian | 7 (1.4) | 1 (1.7) | 6 (1.3) | ||
Black or African American | 61 (12) | 12 (20) | 49 (11) | ||
White | 429 (84.6) | 45 (75.0) | 384 (85.9) | ||
Other | 6 (1.2) | 0 (0) | 6 (1.3) | ||
Education level, n (%) | .05 | ||||
Less than high school | 15 (3) | 2 (3.3) | 13 (2.9) | ||
High-school graduate | 153 (30.2) | 17 (28.3) | 136 (30.4) | ||
Some college | 176 (34.7) | 13 (21.7) | 163 (36.5) | ||
Bachelor’s | 148 (29.2) | 24 (40) | 124 (27.7) | ||
Graduate or professional degree | 15 (3) | 4 (6.7) | 11 (2.5) | ||
Marital status, n (%) | .003 | ||||
Single | 86 (17) | 14 (23.3) | 72 (16.1) | ||
Married | 207 (40.8) | 32 (53.3) | 175 (39.1) | ||
Living as married | 36 (7.1) | 7 (11.7) | 29 (6.5) | ||
Separated | 18 (3.6) | 2 (3.3) | 16 (3.6) | ||
Divorced | 94 (18.5) | 3 (5) | 91 (20.4) | ||
Widowed | 66 (13) | 2 (3.3) | 64 (14.3) | ||
Annual household income, n (%) | >.99 | ||||
Less than US $20,001 | 77 (15.2) | 9 (15) | 68 (15.2) | ||
US $20,001 to $35,000 | 120 (23.7) | 15 (25) | 105 (23.5) | ||
US $35,001 to $50,000 | 94 (18.5) | 11 (18.3) | 83 (18.6) | ||
US $50,001 to $75,000 | 99 (19.5) | 11 (18.3) | 88 (19.7) | ||
US $75,001 or more | 106 (20.9) | 13 (21.7) | 93 (20.8) | ||
Prefer not to say | 11 (2.2) | 1 (1.7) | 10 (2.2) | ||
Clinic distance, n (%) | .04 | ||||
Less than 5 miles | 204 (40.2) | 19 (31.7) | 185 (41.4) | ||
Between 5 and 10 miles | 194 (38.3) | 32 (53.3) | 162 (36.2) | ||
More than 10 miles | 109 (21.5) | 9 (15) | 100 (22.4) | ||
Area, n (%) | .01 | ||||
Urban | 130 (25.6) | 24 (40) | 106 (23.7) | ||
Suburban | 245 (48.3) | 22 (36.7) | 223 (49.9) | ||
Exurban | 15 (3) | 1 (1.7) | 14 (3.1) | ||
Rural | 104 (20.5) | 9 (15) | 95 (21.3) | ||
Blank answer | 13 (2.6) | 4 (6.7) | 9 (2) | ||
General health status, n (%) | .10 | ||||
Poor | 22 (4.3) | 1 (1.7) | 21 (4.7) | ||
Fair | 120 (23.7) | 11 (18.3) | 109 (24.4) | ||
Good | 238 (46.9) | 26 (43.3) | 212 (47.4) | ||
Very good | 113 (22.3) | 18 (30.0) | 95 (21.3) | ||
Excellent | 14 (2.8) | 4 (6.7) | 10 (2.2) | ||
Comorbidity, n (%) | .01 | ||||
Heart condition | 0 (0) | 0 (0) | 0 (0) | ||
Diabetes | 128 (25.2) | 18 (30) | 110 (24.6) | ||
Depression or anxiety | 203 (40) | 35 (58.3) | 168 (37.6) | ||
Chronic kidney disease | 24 (4.7) | 1 (1.7) | 23 (5.1) | ||
Other diseases | 99 (19.5) | 8 (13.3) | 91 (20.4) | ||
No comorbidity | 137 (27) | 7 (11.7) | 130 (29.1) | ||
Hypertension history, n (%) | <.001 | ||||
Less than 1 year | 22 (4.3) | 0 (0) | 22 (4.9) | ||
1 year to less than 2 years | 44 (8.7) | 16 (26.7) | 28 (6.3) | ||
2 years to less than 3 years | 63 (12.4) | 15 (25) | 48 (10.7) | ||
3 years to less than 4 years | 47 (9.3) | 10 (16.7) | 37 (8.3) | ||
4 years to less than 5 years | 44 (8.7) | 4 (6.7) | 40 (8.9) | ||
5 years or more | 287 (56.6) | 15 (25.0) | 272 (60.9) | ||
Hypertension medications, mean (SD) | 1.61 (0.96) | 1.65 (0.73) | 1.61 (0.98) | .74 | |
Other medications, mean (SD) | 2.92 (2.83) | 2.42 (2.32) | 2.98 (2.88) | .15 | |
BP | under control, n (%).53 | ||||
Yes | 422 (83.2) | 53 (88.3) | 369 (82.6) | ||
No | 46 (9.1) | 4 (6.7) | 42 (9.4) | ||
Don’t know or not sure | 39 (7.7) | 3 (5.0) | 36 (8.1) | ||
Systolic BP (mm Hg), mean (SD) | 131.77 (18.15) | 129.24 (23.39) | 132.11 (17.34) | .25 | |
Diastolic BP (mm Hg), mean (SD) | 80.15 (11.80) | 81.64 (13.62) | 79.96 (11.555) | .31 | |
RBPM awareness, n (%) | <.001 | ||||
Yes | 165 (32.5) | 57 (95.0) | 108 (24.2) | ||
No | 342 (67.5) | 3 (5.0) | 339 (75.8) |
aRBPM: remote blood pressure monitoring.
bBP: blood pressure.
BP Self-Monitoring and Telemonitoring Behaviors
Overall, about two-thirds (335/507, 66.1%) of the respondents measured their BP routinely at home with varying frequencies of BP measurement (
). About 21% (106/507) of all respondents do not measure their BP routinely. Also, 67.5% (342/507) of the respondents were unaware of RBPM and 68.8% (349/507) did not know if their clinic offers RBPM services. Awareness of RBPM was reported in 32.5% (165/507) of the respondents and 34.5% (57/165) of those who were aware reported participation in RBPM ( ). Characteristics of those who were aware of RBPM versus those who were unaware are shown in . The respondents who were aware of RBPM but not participating in RBPM were older and most of them (65/108, 60.2%) have had hypertension for 5 years or more compared with those participating in RBPM ( ). Taking BP medications as prescribed by the health care provider was the most common self-BP control behavior among all respondents.Most respondents in the RBPM group measure their BP at home (55/60, 91.7%) and 61.7% (37/60) engage in daily BP measurement compared with 62.6% (280/447) and 25.1% (112/447), respectively, among the non-RBPM group (
). A greater number of those in the RBPM group reported tracking their BP measurements with mHealth (37/60, 61.7%) than those in the non-RBPM group (70/447, 15.6%).Among those participating in RBPM, the most reported RBPM provider was doctors, while RBPM frequency was mostly daily and several times per week (
). The electronic health records or patient portal was the most common channel of RBPM communication between the respondents and their health care providers. The feedback message to the respondents were mainly acknowledgement of BP measurement receipt and interpretation of measurement as low, high, or normal ( ).The top 2 reasons for not participating in RBPM were that doctors have yet to ask them to participate and their lack of awareness of RBPM (
). About three-quarters of those not participating in RBPM reported that they would likely participate in RBPM if offered.Technology Health Behaviors
Most of the 507 respondents reported having a smartphone (469/507, 92.5%), tablet computer (323/507, 63.7%), laptop or desktop computer (440/507, 86.8%), health-related apps (299/507, 59%), and home BP monitoring device (399/507, 78.7%;
). About three-quarters of the respondents have communicated with their doctor or doctor’s office through emails (377/507, 74.4%) or the internet and checked their medical test results electronically (381/507, 75.1%). About half reported that they made health decisions (277/507, 54.6%) and achieved health goals (235/507, 46.4%) with mHealth, and shared health information electronically with their health care providers (252/507, 49.7%; ).The ownership of tablet computers and health-related apps was significantly higher among the RBPM group than the non-RBPM groups (85% vs 60.9%; 93.3% vs 54.4%; P<.001 respectively). The RBPM group also had a significantly higher proportion of people who own and use home BP monitoring devices than the non-RBPM group (96.7% vs 64.7%, P<.001). All the technology use health behaviors were observed more significantly in the RBPM group than the non-RBPM group (
).Among the 108 respondents who reported not having a home BP device, the top reported reasons for not owning a home BP monitoring device included dependence on a health provider for BP measurement (46/108, 42.6%), not being able to afford one (38/108, 35.2%), feeling that BP is under control (23/108, 21.3%), thinking that they do not need the device (20/108, 18.5%), and not having seen a device that works well for them (20/108,18.5%).
shows the patients’ interaction preferences with their health care provider regarding their BP management. Overall, the most preferred mode of patient-provider interaction was in-person clinic visits, while the least preferred was video visits. Among the electronic communication methods, phone calls were the most preferred, followed by email, then SMS text messages. Video visits remained the least preferred interaction method. There was no difference in the order of interaction preferences across age and educational groups. The order of preferences for patient-provider interaction channels remained the same in the RBPM and non-RBPM groups as in the overall participants.
Predictors of RBPM Participation
Overall, the statistically significant predictors of participation in RBPM were awareness of RBPM (adjusted odds ratio [AOR] 34.65, 95% CI 11.35‐150.31; P<.001) and sharing electronic health information with a health care provider (AOR 4.90, 95% CI 1.39‐21.64; P=.01) (
). Age, education level, marital status, clinic distance, ownership of technology, and other behavioral variables were not statistically significant predictors. Sharing electronic health information with a health care provider was the only significant predictor (AOR 6.99, 95% CI 1.62‐47.44; P=.007) of RBPM participation among those who were aware of RBPM ( ).Predictor variables and categories | Adjusted odds ratio (95% CI) | P values | |
Age | 0.99 (0.94-1.06) | .97 | |
Sex | |||
Male | 0.80 (0.32-1.96) | .63 | |
Education level | |||
Some college | 0.69 (0.01-34.93) | .86 | |
College graduate or more | 24.81 (0.38-1938.02) | .13 | |
Race | |||
American Indian or Alaska Native or Asian or Black or African American or other races | 0.62 (0.21-1.71) | .36 | |
Marital status | |||
Married | 1.33 (0.45-4.10) | .61 | |
Previously married | 0.53 (0.12-2.17) | .38 | |
Clinic distance from residence | |||
Between 5 and 10 miles | 1.42 (0.55-3.73) | .47 | |
More than 10 miles | 0.64 (0.18-2.20) | .48 | |
RBPM awareness | |||
Yes | 34.65 (11.35-150.31) | <.001 | |
BP | under control|||
Yes | 0.32 (0.06-1.78) | .18 | |
Don’t know or unsure | 0.23 (0.02-2.78) | .25 | |
Have tablet | |||
Yes | 1.14 (0.40-3.38) | .81 | |
Have smartphone | |||
Yes | 0.86 (0.05-24.04) | .92 | |
Have basic cellphone only | |||
Yes | 2.30 (0.79-6.87) | .13 | |
Have computer | |||
Yes | 0.81 (0.23-3.17) | .25 | |
Have health apps | |||
Yes | 2.31 (0.58-12.03) | .24 | |
Electronic communication with doctor or doctor’s office via email or internet | |||
Yes | 1.11 (0.19-9.57) | .91 | |
Sent or received SMS text message from doctor | |||
Yes | 1.90 (0.63-6.38) | .26 | |
Shared health information from electronic device, tablet, or smartphone with health provider | |||
Yes | 4.90 (1.39-21.64) | .01 | |
Made health decision with mobile health | |||
Yes | 0.34 (0.08-1.26) | .11 | |
Achieved health goals with mobile health | |||
Yes | 2.55 (0.78-9.15) | .12 | |
Have checked medical test results electronically | |||
Yes | 0.36 (0.08-1.48) | .16 | |
Time since hypertension diagnosis | |||
Less than 1 year | 0.29 (0.002-5.29) | .46 | |
1 year - <2 years | 1.80 (0.40-7.93) | .44 | |
2 years - <3 years | 2.02 (0.57-7.10) | .27 | |
3 years - <4 years | 0.86 (0.19-3.54) | .83 | |
4 years - <5 years | 0.55 (0.11-2.31) | .43 | |
Age and education interaction | |||
Age and some college education | 0.98 (0.91-1.05) | .58 | |
Age and college graduate or more | 0.92 (0.85-1.00) | .47 |
aRBPM: remote blood pressure monitoring.
bReference: female sex.
cReference: less than college education.
dReference: White race.
eReference: never married.
fReference: clinic distance less than 5 miles from residence.
gReference: no response.
hBP: blood pressure.
iReference: 5 years or more.
jReference: age and less than college education.
Discussion
Principal Findings
We found that more than three-quarters of patients with hypertension were not participating in RBPM. Nonparticipation in RBPM was mostly due to not being asked to participate by their health care providers and lack of awareness of RBPM, as only one-third of the patients were aware of RBPM. These findings show health care providers’ important role in helping patients take up health-improving strategies. A doctor’s referral or recommendation has been identified as influential in a patient’s telemedicine utilization [
]. A related study on the utilization of teleconsultation among adult epileptic patients in a low-income setting showed that only about 32% had used teleconsultation and more than half (58%) of the patients were not aware of teleconsultation services [ ]. Patients will likely take up health-improving programs like RBPM if they know the program and its benefits. A review of the impact of telemedicine during the COVID-19 pandemic by Omboni et al [ ], identified patients’ awareness as an important factor in the uptake of digital health services. This finding is also supported by the high number (74.9%) of non-RBPM patients in our study who reported they would likely participate in RBPM if offered. Another study [ ] assessing willingness to take up telemonitoring programs among patients with diabetes and/or hypertension found that more than half (52.5%) of the respondents were willing to take up telemonitoring programs. Despite the differences in proportions of patients willing to participate in BP telemonitoring in these two studies, it shows that a sizable number would likely participate had it been brought to their awareness or if they received a recommendation. A concerted effort among all health care providers (physicians, nurses, pharmacists, etc) toward RBPM recommendations to their patients could provide the encouragement and support needed to get more patients with hypertension to participate in RBPM. However, the recommendation of the RBPM program depends on its availability and accessibility in health care institutions [ , ]. It therefore calls for the provision of the technical infrastructure (eg, adequate RBPM system and home BP monitoring device for patients) and appropriate reimbursements to aid health care providers in rendering RBPM services.Our study showed that phone calls were the most preferred electronic communication method regardless of participation or nonparticipation in RBPM. This could be because of the simplicity of making and answering calls as easy-to-use technology is a required feature of digital services [
, ]. It could also be because over 80% of our participants were 50 years and above. Older patients have been found to prefer phone call interactions over other electronic modes of communication [ - ]. It is important for health care providers or office staff to identify the patients’ electronic communication preferences regarding their health management [ ]. The reimbursement of phone-based care during the COVID-19 pandemic greatly improved patient care [ ]. It is therefore quite unfortunate that reimbursement of this health improvement policy will end by December 31, 2024, according to the United States Consolidated Appropriation Act, 2023 [ ]. Given the health benefits of phone-based health management, health care policymakers should rather make it permanent and extend similar reimbursement to RBPM services to help health care providers improve their patients’ health. Engaging patients electronically through their preferred medium would likely promote adherence to health management protocols.In addition to awareness, sharing health information from electronic devices with health care providers was positively associated with RBPM participation in the adjusted analyses. This previous technology-related health behavior shows that experience with an action makes it more likely to engage in a similar action. This finding is supported by a study among patients with hypertension where prior communication with the doctor or doctor’s office through email or the internet was a significant predictor of communicating with the doctor via SMS text messaging [
]. Health care institutions should consider making electronic communications channels such as SMS texting, emails, and so on, available and accessible for their patients. Measures to improve awareness of RBPM among patients with hypertension as well as encourage use of electronic health devices and sharing of their health information may increase participation in RBPM.RBPM is a valuable way of engaging patients with hypertension in their disease management to achieve BP control and mitigate the consequences of uncontrolled BP. However, more must be done to get patients to embrace this digital service option. The availability of secure RBPM infrastructure accessible to patients is essential. Proactive actions like building RBPM into routine health care and ensuring that every patient diagnosed with hypertension has access to it could go a long way in increasing participation. Reimbursement of RBPM services and insurance coverage of home BP monitoring devices could help increase RBPM accessibility to patients. It may be helpful for health systems to spread the awareness and benefits of RBPM to the general population of patients with hypertension but start the RBPM service with the most severe cases and gradually expand it to all patients according to their needs.
Study Limitations
This study is limited by its cross-sectional design, and the generalizability may be limited because the sample included mostly non-Hispanic White patients with hypertension living mainly in urban and suburban areas. Over 80% of our sample reported having their BP under control, and most (72%) reported being in good health. Therefore, a more diverse population based on race, ethnicity, residential area, BP control status, and health status is warranted for future studies. A self-administered electronic survey may have excluded those not technology savvy from participating and introduced bias in the responses. As the study is related to technology use, respondents could be overly positive or supportive of the RBPM. The study was also limited to people with hypertension who were enrolled in the Qualtrics panel. However, our study is strengthened by having a large sample size to make predictions. We also recruited representatives from all age brackets and educational levels to mitigate age and education biases.
Conclusion
These results suggest low RBPM participation among patients with hypertension in the United States. Creating awareness of RBPM and encouraging patients to share their health information electronically with their health care providers may increase RBPM participation. This calls for health care policies ensuring RBPM availability, accessibility, and service reimbursement in our health care systems.
Disclaimer
Generative artificial intelligence was not used in preparing any part of this manuscript.
Data Availability
This project's data are available upon request made to the authors.
Authors' Contributions
KBF, MPD, and CEE conceived the project idea. CEE conducted the analysis and wrote the manuscript. MPD, ABC, CAL, LRB and KBF reviewed the manuscript. All authors approved the final version of the manuscript.
Conflicts of Interest
LRB is the Editor in Chief of JMIR mHealth and uHealth.
Self–blood pressure monitoring behaviors.
DOCX File, 18 KBRespondents’ characteristics stratified by remote blood pressure monitoring awareness.
DOCX File, 34 KBAware but not participating in remote blood pressure monitoring.
DOCX File, 25 KBRemote blood pressure monitoring (RBPM) strategies.
DOCX File, 16 KBReasons for not participating and likelihood of participating in remote blood pressure monitoring.
DOCX File, 16 KBTechnology ownership.
DOCX File, 17 KBTechnology use.
DOCX File, 17 KBPredictors of remote blood pressure monitoring participation among those who are aware.
DOCX File, 19 KBChecklist for Reporting Results of Internet E-Surveys (CHERRIES).
DOCX File, 18 KBReferences
- Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. Apr 2015;17(4):21. [CrossRef] [Medline]
- Omboni S, Panzeri E, Campolo L. E-Health in hypertension management: an insight into the current and future role of blood pressure telemonitoring. Curr Hypertens Rep. Jun 6, 2020;22(6):42. [CrossRef] [Medline]
- Wang S, Leung M, Leung SY, et al. Safety, feasibility, and acceptability of telemedicine for hypertension in primary care: a proof-of-concept and pilot randomized controlled trial (SATE-HT). J Med Syst. Mar 11, 2023;47(1):34. [CrossRef] [Medline]
- Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. Sep 2017;14(9):e1002389. [CrossRef] [Medline]
- Parati G, Dolan E, McManus RJ, Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens. Jul 2018;20(7):1128-1132. [CrossRef]
- Milani RV, Lavie CJ, Bober RM, Milani AR, Ventura HO. Improving hypertension control and patient engagement using digital tools. Am J Med. Jan 2017;130(1):14-20. [CrossRef] [Medline]
- Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. Mar 1, 2013;6(2):157-163. [CrossRef] [Medline]
- Kaihara T, Intan-Goey V, Scherrenberg M, et al. Automatic transmission of home blood pressure data can be effective in managing hypertension: a systematic review and meta-analysis. Eur Heart J Dig Health. Dec 22, 2022;3(4):638-653. [CrossRef]
- Wu D, An J, Yu P, et al. Patterns for patient engagement with the hypertension management and effects of electronic health care provider follow-up on these patterns: cluster analysis. J Med Internet Res. Sep 28, 2021;23(9):e25630. [CrossRef] [Medline]
- Hallberg I, Ranerup A, Bengtsson U, Kjellgren K. Experiences, expectations and challenges of an interactive mobile phone-based system to support self-management of hypertension: patients’ and professionals’ perspectives. Patient Prefer Adherence. 2018;12:467-476. [CrossRef] [Medline]
- Kalańska-Łukasik B, Gładyś A, Jadczyk T, Gruz-Kwapisz M, Wojakowski W, Kowalska M. Readiness for telemedical services in patients with cardiovascular diseases: cross-sectional study. JMIR Form Res. Oct 18, 2022;6(10):e33769. [CrossRef] [Medline]
- Price-Haywood EG, Harden-Barrios J, Ulep R, Luo Q. eHealth Literacy: patient engagement in identifying strategies to encourage use of patient portals among older adults. Popul Health Manag. Dec 2017;20(6):486-494. [CrossRef] [Medline]
- Wood PW, Boulanger P, Padwal RS. Home blood pressure telemonitoring: rationale for use, required elements, and barriers to implementation in Canada. Can J Cardiol. May 2017;33(5):619-625. [CrossRef] [Medline]
- Khanijahani A, Akinci N, Quitiquit E. A systematic review of the role of telemedicine in blood pressure control: focus on patient engagement. Curr Hypertens Rep. Jul 2022;24(7):247-258. [CrossRef] [Medline]
- Nozato Y, Yamamoto K, Rakugi H. Hypertension management before and under the COVID-19 pandemic: lessons and future directions. Hypertens Res. Jun 2023;46(6):1471-1477. [CrossRef] [Medline]
- Yatabe J, Yatabe MS, Ichihara A. The current state and future of internet technology-based hypertension management in Japan. Hypertens Res. Mar 2021;44(3):276-285. [CrossRef] [Medline]
- Roberts S, Chaboyer W, Gonzalez R, Marshall A. Using technology to engage hospitalised patients in their care: a realist review. BMC Health Serv Res. Jun 6, 2017;17(1):1-15. [CrossRef] [Medline]
- Bosak K, Park SH. Characteristics of adults seeking health care provider support facilitated by mobile technology: secondary data analysis. JMIR Hum Factors. Dec 21, 2017;4(4):e33. [CrossRef] [Medline]
- Madrigal L, Escoffery C. Electronic health behaviors among US adults with chronic disease: cross-sectional survey. J Med Internet Res. Mar 5, 2019;21(3):e11240. [CrossRef] [Medline]
- Eze CE, West BT, Dorsch MP, et al. Predictors of smartphone and tablet use among patients with hypertension: secondary analysis of Health Information National Trends Survey Data. J Med Internet Res. Jan 24, 2022;24(1):e33188. [CrossRef] [Medline]
- Hanley J, Ure J, Pagliari C, Sheikh A, McKinstry B. Experiences of patients and professionals participating in the HITS home blood pressure telemonitoring trial: A qualitative study. BMJ Open. May 28, 2013;3(5):1-10. [CrossRef] [Medline]
- Grant S, Hodgkinson J, Schwartz C, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. Sep 2019;69(686):e612-e620. [CrossRef] [Medline]
- Koopman RJ, Wakefield BJ, Johanning JL, et al. Implementing home blood glucose and blood pressure telemonitoring in primary care practices for patients with diabetes: lessons learned. Telemed J E Health. Mar 2014;20(3):253-260. [CrossRef] [Medline]
- Ware P, Shah A, Ross HJ, et al. Challenges of telemonitoring programs for complex chronic conditions: randomized controlled trial with an embedded qualitative study. J Med Internet Res. Jan 26, 2022;24(1):e31754. [CrossRef] [Medline]
- Baratta J, Brown-Johnson C, Safaeinili N, et al. Patient and health professional perceptions of telemonitoring for hypertension management: qualitative study. JMIR Form Res. Jun 10, 2022;6(6):e32874. [CrossRef] [Medline]
- Aquino M, Griffith J, Vattaparambil T, Munce S, Hladunewich M, Seto E. Patients’ and providers’ perspectives on and needs of telemonitoring to support clinical management and self-care of people at high risk for preeclampsia: qualitative study. JMIR Hum Factors. Feb 7, 2022;9(1):e32545. [CrossRef] [Medline]
- Sin DYE, Guo X, Yong DWW, et al. Assessment of willingness to tele-monitoring interventions in patients with type 2 diabetes and/or hypertension in the public primary healthcare setting. BMC Med Inform Decis Mak. Jan 28, 2020;20(1):11. [CrossRef] [Medline]
- Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. Feb 23, 2021;143(8):e254-e743. [CrossRef] [Medline]
- Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. Apr 2013;35(2):121-126. [CrossRef] [Medline]
- Bujang MA, Sa’at N, Sidik T, Lim CJ. Sample size guidelines for logistic regression from observational studies with large population. Malays J Med Sci. 2018;25(4):122-130. [CrossRef]
- Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. Sep 29, 2004;6(3):1-6. [CrossRef] [Medline]
- Westat. Health Information National Trends Survey 5 (HINTS 5) cycle 2 methodology report. National Cancer Institute; 2018. URL: https://hints.cancer.gov/docs/methodologyreports/HINTS5_Cycle_2_Methodology_Report.pdf [Accessed 2024-12-10]
- Puhr R, Heinze G, Nold M, Lusa L, Geroldinger A. Firth’s logistic regression with rare events: accurate effect estimates and predictions? Stat Med. Jun 30, 2017;36(14):2302-2317. [CrossRef] [Medline]
- Mansournia MA, Geroldinger A, Greenland S, Heinze G. Separation in logistic regression: causes, consequences, and control. Am J Epidemiol. Apr 1, 2018;187(4):864-870. [CrossRef] [Medline]
- Lumley T, Scott A. AIC and BIC for modeling with complex survey data. J Surv Stat Methodol. Mar 1, 2015;3(1):1-18. [CrossRef]
- Leach WD. If you bill it, they will come: a literature review on clinical outcomes, cost-effectiveness, and reimbursement for telemedicine. California Telemedicine and eHealth Center; 2009. URL: https://www.researchgate.net/profile/William-Leach-2/publication/299129584_If_You_Bill_It_They_Will_Come_A_Literature_Review_on_Clinical_Outcomes_Cost-Effectiveness_and_Reimbursement_for_Telemedicine/links/56eee2c308ae59dd41c706e1/If-You-Bill-It-They-Will-Come-A-Literature-Review-on-Clinical-Outcomes-Cost-Effectiveness-and-Reimbursement-for-Telemedicine.pdf [Accessed 2024-12-10]
- Choudhary N, Chakravarty K, Kharbanda PS, Lal V, Baishya J. Satisfaction and effectiveness of tele-medicine in follow-up of people with epilepsy in a resource-poor setting during COVID-19. Epilepsy Behav. Mar 2022;128:108569. [CrossRef] [Medline]
- Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Heal. 2022;1:7-35. [CrossRef]
- Harst L, Lantzsch H, Scheibe M. Theories predicting end-user acceptance of telemedicine use: systematic review. J Med Internet Res. May 21, 2019;21(5):e13117. [CrossRef] [Medline]
- Yuan S, Hussain SA, Hales KD, Cotten SR. What do they like? Communication preferences and patterns of older adults in the United States: the role of technology. Educ Gerontol. Mar 3, 2016;42(3):163-174. [CrossRef]
- Clarke MA, Fruhling AL, Sitorius M, Windle TA, Bernard TL, Windle JR. Impact of age on patients’ communication and technology preferences in the era of meaningful use: mixed methods study. J Med Internet Res. Jun 1, 2020;22(6):e13470. [CrossRef] [Medline]
- Alexander KE, Ogle T, Hoberg H, Linley L, Bradford N. Patient preferences for using technology in communication about symptoms post hospital discharge. BMC Health Serv Res. Feb 15, 2021;21(1):141. [CrossRef] [Medline]
- Chow R, Forde B, Sawatzky R, et al. Digital health technology and hypertension management: a qualitative analysis of patient and specialist provider preferences on data tracking. Conn Health. 2022;1(2):72-84. [CrossRef]
- Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Com Health. Aug 2020;8(3):e000530. [CrossRef]
- State telehealth policy for email, phone & fax. Center for Connected Health Policy. URL: https://www.cchpca.org/topic/email-phone-fax [Accessed 2024-12-10]
Abbreviations
AOR: adjusted odds ratio |
BP: blood pressure |
CHERRIES: Checklist for Reporting Results of Internet E-Surveys |
mHealth: mobile health |
RBPM: remote blood pressure monitoring |
Edited by Amaryllis Mavragani; submitted 31.01.24; peer-reviewed by Alicja Bortkiewicz, Kamakshi Lakshminarayan; final revised version received 14.10.24; accepted 15.10.24; published 23.12.24.
Copyright© Chinwe E Eze, Michael P Dorsch, Antoinette B Coe, Corey A Lester, Lorraine R Buis, Karen B Farris. Originally published in JMIR Formative Research (https://formative.jmir.org), 23.12.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.